ALPINE GROUP PARTNERS, LLC. for EMERGENT BIOSOLUTIONS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEENAN AUSTIN REED | Chief of Staff, Rep. Donald McEachin; Deputy Chief of Staff, Rep. Frederica S. Wilson |
| COURTNEY JOHNSON | — |
Aviation/Airlines/Airports AVI
FAA reauthorization - increasing access to naloxone
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEENAN AUSTIN REED | — |
| COURTNEY JOHNSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.